Title:
酸化的侵襲効果を治療するためのマンガフォジピルの使用
Document Type and Number:
Japanese Patent JP4371197
Kind Code:
B2
Abstract:
The invention concerns the use of Mangafodipir to obtain a medicine for preventive or curative treatment of hepatocellular deficiencies.
Inventors:
Bateau, Frederick
Weil, Bernard
Weil, Bernard
Application Number:
JP2002584924A
Publication Date:
November 25, 2009
Filing Date:
April 26, 2002
Export Citation:
Assignee:
UNIVERSITE PARIS DESCARTES
International Classes:
A61K31/6615; A61K31/663; A61K31/444; A61P1/16
Domestic Patent References:
| JP4020285A |
Foreign References:
| WO1997049409A1 |
Other References:
Brurok H,Biochem Biophys Res Commun.,1999年,Vol.254, No.3,pp768-72
KITAHARA,J. et al,Possible involvement of active oxygen species in selenite toxicity in isolated rat hepatocytes,Arch Toxicol,1993年,Vol.67, No.7,p.497-501
MIESEL,R. et al,Hepatoprotective reactivity of a copper-di-Schiffbase active centre analogue of Cu2Zn2 superoxide dismutase,Gen Pharmacol,1995年,Vol.26, No.6,p.1261-6
KITAHARA,J. et al,Possible involvement of active oxygen species in selenite toxicity in isolated rat hepatocytes,Arch Toxicol,1993年,Vol.67, No.7,p.497-501
MIESEL,R. et al,Hepatoprotective reactivity of a copper-di-Schiffbase active centre analogue of Cu2Zn2 superoxide dismutase,Gen Pharmacol,1995年,Vol.26, No.6,p.1261-6
Attorney, Agent or Firm:
Shintaro Nogawa